Fig. 1From: NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancerNAP1L1 overexpression in serous ovarian cancer tissues with IHC. A-B NAP1L1 overexpression in serous ovarian cancer tissues with IHC, NAP1L1 expression in normal context and serous ovarian cancer tissues (P < 0.012). *p < 0.05, **p < 0.01, and ***p < 0.001Back to article page